Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice

Abstract

Prime editors (PEs) mediate genome modification without utilizing double-stranded DNA breaks or exogenous donor DNA as a template. PEs facilitate nucleotide substitutions or local insertions or deletions within the genome based on the template sequence encoded within the prime editing guide RNA (pegRNA). However, the efficacy of prime editing in adult mice has not been established. Here we report an NLS-optimized SpCas9-based prime editor that improves genome editing efficiency in both fluorescent reporter cells and at endogenous loci in cultured cell lines. Using this genome modification system, we could also seed tumor formation through somatic cell editing in the adult mouse. Finally, we successfully utilize dual adeno-associated virus (AAVs) for the delivery of a split-intein prime editor and demonstrate that this system enables the correction of a pathogenic mutation in the mouse liver. Our findings further establish the broad potential of this genome editing technology for the directed installation of sequence modifications in vivo, with important implications for disease modeling and correction.

References 50

1. 1.

   Porteus MH. A new class of medicines through DNA Editing. N. Engl. J. Med. 2019;380:947-959.

   Not in our library10.1056/nejmra1800729

2. 2.

   Panier S, Boulton SJ. Double-strand break repair: 53BP1 comes into focus. Nat. Rev. Mol. Cell Biol. 2014;15:7-18.

   Not in our library10.1038/nrm3719

3. 3.

   Suzuki K, et al. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature. 2016;540:144-149.

   Not in our library10.1038/nature20565

4. 4.

   Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications. Nat. Rev. Mol. Cell Biol. 2019;20:490-507.

   Not in our library10.1038/s41580-019-0131-5

5. 5.

   Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 2018;19:770-788.

   Not in our library10.1038/s41576-018-0059-1

6. 6.

   Anzalone AV, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576:149-157.

   Not in our library10.1038/s41586-019-1711-4

7. 7.

   Lin Q, et al. Prime genome editing in rice and wheat. Nat. Biotechnol. 2020;38:582-585.

   Not in our library10.1038/s41587-020-0455-x

8. 8.
   Prime editing for functional repair in patient-derived disease models · 2020

   No notice
9. 9.
   Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids · 2021

   No notice
10. 10.
    Efficient generation of mouse models with the prime editing system · 2020

    No notice
11. 11.

    Aida, T. et al. Prime editing primarily induces undesired outcomes in mice. bioRxiv 2020.2008.2006.239723 (2020).

    Not in our library

12. 12.

    Wu Y, et al. Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat. Med. 2019;25:776-783.

    Not in our library10.1038/s41591-019-0401-y

13. 13.

    Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol.36, 843–846 (2018).

    Not in our library10.1038/nbt.4172

14. 14.

    Zafra, M. P. et al. Optimized base editors enable efficient editing in cells, organoids and mice. Nat. Biotechnol.36, 888–893 (2018).

    Not in our library10.1038/nbt.4194

15. 15.

    Song C-Q, et al. Adenine base editing in an adult mouse model of tyrosinaemia. Nat. Biomed. Eng. 2020;4:125-130.

    Not in our library10.1038/s41551-019-0357-8

16. 16.

    Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science368, 290–296 (2020).

    Not in our library10.1126/science.aba8853

17. 17.

    Ray M, Tang R, Jiang Z, Rotello VM. Quantitative tracking of protein trafficking to the nucleus using cytosolic protein delivery by nanoparticle-stabilized nanocapsules. Bioconjugate Chem. 2015;26:1004-1007.

    Not in our library10.1021/acs.bioconjchem.5b00141

18. 18.

    Makkerh JP, Dingwall C, Laskey RA. Comparative mutagenesis of nuclear localization signals reveals the importance of neutral and acidic amino acids. Curr. Biol. 1996;6:1025-1027.

    Not in our library10.1016/s0960-9822(02)00648-6

19. 19.

    Ran FA, et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature. 2015;520:186-191.

    Not in our library10.1038/nature14299

20. 20.

    Kleinstiver BP, et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat. Biotechnol. 2015;33:1293-1298.

    Not in our library10.1038/nbt.3404

21. 21.

    Certo MT, et al. Tracking genome engineering outcome at individual DNA breakpoints. Nat. Methods. 2011;8:671-676.

    Not in our library10.1038/nmeth.1648

22. 22.

    Mir A, et al. Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing. Nat. Commun. 2018;9:2641.

    Not in our library10.1038/s41467-018-05073-z

23. 23.

    Iyer, S. et al. Efficient homology-directed repair with circular ssDNA donors. bioRxiv 864199 (2019).

    Not in our library10.1089/crispr.2022.0058

24. 24.

    Dean M, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996;273:1856-1862.

    Not in our library10.1126/science.273.5283.1856

25. 25.

    Liu R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367-377.

    Not in our library10.1016/s0092-8674(00)80110-5

26. 26.

    Samson M, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722-725.

    Not in our library10.1038/382722a0

27. 27.

    Bolukbasi MF, et al. Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing. Nat. Commun. 2018;9:4856.

    Not in our library10.1038/s41467-018-07310-x

28. 28.

    Loring HS, Flotte TR. Current status of gene therapy for alpha-1 antitrypsin deficiency. Expert Opin. Biol. Ther. 2015;15:329-336.

    Not in our library10.1517/14712598.2015.978854

29. 29.

    Carlson JA, et al. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J. Clin. Invest. 1989;83:1183-1190.

    Not in our library10.1172/jci113999

30. 30.

    Gaudelli NM, et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature. 2017;551:464-471.

    Not in our library10.1038/nature24644

31. 31.

    Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6:1258-1266.

    Not in our library10.1038/sj.gt.3300947

32. 32.

    Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology. 2015;149:1226-1239.

    Not in our library10.1053/j.gastro.2015.05.061

33. 33.

    Liu P, et al. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis. Hepatology. 2017;66:167-181.

    Not in our library10.1002/hep.29183

34. 34.

    Marquardt JU, Andersen JB, Thorgeirsson SS. Functional and genetic deconstruction of the cellular origin in liver cancer. Nat. Rev. Cancer. 2015;15:653-667.

    Not in our library10.1038/nrc4017

35. 35.

    Wang, D. A.-O., Tai, P. A.-O. & Gao, G. A.-O. Adeno-associated virus vector as a platform for gene therapy delivery. 18, 358–378 (2019).

    Not in our library10.1038/s41573-019-0012-9

36. 36.

    Levy JM, et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 2020;4:97-110.

    Not in our library10.1038/s41551-019-0501-5

37. 37.

    Zettler J, Schütz V, Mootz HD. The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction. FEBS Lett. 2009;583:909-914.

    Not in our library10.1016/j.febslet.2009.02.003

38. 38.

    Wright AV, et al. Rational design of a split-Cas9 enzyme complex. Proc. Natl Acad. Sci. USA. 2015;112:2984-2989.

    Not in our library10.1073/pnas.1501698112

39. 39.
    UDiTaS™, a genome editing detection method for indels and genome rearrangements · 2018

    No notice
40. 40.

    Yao X, et al. CRISPR/Cas9-mediated precise targeted integration in vivo using a double cut donor with short homology arms. EBioMedicine. 2017;20:19-26.

    Not in our library10.1016/j.ebiom.2017.05.015

Cited by papers we hold 13

• Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease · 2025
  Not checked
• Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy · 2024
  Corrected
• Exploring treatment options in cancer: tumor treatment strategies · 2024
  No notice
• Efficient prime editing in mouse brain, liver and heart with dual AAVs · 2023
  No notice
• Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing · 2023
  No notice
• Phage-assisted evolution and protein engineering yield compact, efficient prime editors · 2023
  No notice
• CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer · 2022
  Not checked
• TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor · 2022
  Not checked
• Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure · 2022
  No notice
• Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing · 2022
  No notice
• piggyPrime: High-Efficacy Prime Editing in Human Cells Using piggyBac-Based DNA Transposition · 2021
  Not checked
• Enhanced prime editing systems by manipulating cellular determinants of editing outcomes · 2021
  No notice
• Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.